KBC Group
ORGO icon

KBC Group’s Organogenesis Holdings ORGO Stock Holding History

KBC Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,487
Closed -$15K – 1522
2022
Q4 		$15K Hold
5,487
– – ﹤0.01% 1513
2022
Q3 		$18K Hold
5,487
– – ﹤0.01% 1528
2022
Q2 		$27K Buy
+5,487
New +$33.8K ﹤0.01% 1506

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

KBC Group's ORGO Position: Q1 2023 in Review

KBC Group sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 5,487 shares — an estimated $15K sold.

KBC Group first reported a position in ORGO in Q2 2022 and held it in 3 quarters. The position peaked at $27K in Q2 2022. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

  • KBC Group reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
  • KBC Group sold 5,487 Organogenesis Holdings shares in Q1 2023, an estimated $15K.
  • KBC Group first reported a position in Organogenesis Holdings in Q2 2022 and held it in 3 quarters.
  • KBC Group's Organogenesis Holdings position peaked at $27K in Q2 2022.
  • 131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on KBC Group's 13F filing for Q1 2023, filed 4 May 2023.